Table 5.

Miscellaneous additional gene expression changes in plasma cells

Mean fold change5-150Accession no.PC5-151B5-151
Increased in plasma cells     
 Doc2b 1107.9 D85037 
 CD43 362.3 X17018 
 Reelin 321.6 U24703 
 EGP314 320.8 M76124 
 Syndecan-1 307 Z22532 A  
 Secreted leukocyte protease inhibitor 103.6 AF002719 
 Sel1L 17.7 AF063095 
 CD44 15.8 X66084 
 BCMA 15.5 AF061505 
 Neuropilin-1 6.6 D50086 
 PC-1 6.2 J02700 P  
Decreased in plasma cells     
 ApoE 363.8 D00466 
 CD19 235.1 M28240 
 CD22 220.3 L02844 
 L-selectin 90.2 M36058 
 CD37 20.8 U18372 
 CD38 12.4 L11332 
 CD40 11.4 M83312 
 ICAM-1 7.3 M90551 
 CD79A X13450 
 BCL-10 3.5 AJ006289 
Mean fold change5-150Accession no.PC5-151B5-151
Increased in plasma cells     
 Doc2b 1107.9 D85037 
 CD43 362.3 X17018 
 Reelin 321.6 U24703 
 EGP314 320.8 M76124 
 Syndecan-1 307 Z22532 A  
 Secreted leukocyte protease inhibitor 103.6 AF002719 
 Sel1L 17.7 AF063095 
 CD44 15.8 X66084 
 BCMA 15.5 AF061505 
 Neuropilin-1 6.6 D50086 
 PC-1 6.2 J02700 P  
Decreased in plasma cells     
 ApoE 363.8 D00466 
 CD19 235.1 M28240 
 CD22 220.3 L02844 
 L-selectin 90.2 M36058 
 CD37 20.8 U18372 
 CD38 12.4 L11332 
 CD40 11.4 M83312 
 ICAM-1 7.3 M90551 
 CD79A X13450 
 BCL-10 3.5 AJ006289 

PC indicates plasma cells; B, B cells.

F5-150

Calculated using normalized average difference values.

F5-151

Present (P) and absent (A) determinations.

Close Modal

or Create an Account

Close Modal
Close Modal